DHFR and neoplasm: In tumor cells from a SCLC (small cell lung cancer) patient who received methotrexate (MTX), a large quantity of DMs containing dihydrofolate reductase (DHFR), a drug-resistance gene, was amplified and overexpressed (Curt et al., 1983).